MPW
ABBV icon

MASECO Private Wealth’s AbbVie ABBV Stock Holding History

MASECO Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.19M Sell
5,475
-36
-0.7% -$7.99K 0.04% 57
2025
Q4 		$1.26M Sell
5,511
-2,780
-34% -$633K 0.05% 51
2025
Q3 		$1.92M Buy
8,291
+1,000
+14% +$204K 0.09% 30
2025
Q2 		$1.35M Buy
+7,291
New +$1.36M 0.05% 56

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MASECO Private Wealth's ABBV Position: Q1 2026 in Review

MASECO Private Wealth reduced its AbbVie (ABBV) stake by 0.65% in Q1 2026, selling an estimated $7.99K and leaving 5,475 shares worth $1.19M. The position accounts for 0.04% of the portfolio, ranked #57.

MASECO Private Wealth first reported a position in ABBV in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.92M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • MASECO Private Wealth held 5,475 shares of AbbVie worth $1.19M as of Q1 2026.
  • MASECO Private Wealth sold 36 AbbVie shares in Q1 2026, an estimated $7.99K.
  • AbbVie made up 0.04% of MASECO Private Wealth's portfolio in Q1 2026, its #57 holding.
  • MASECO Private Wealth first reported a position in AbbVie in Q2 2025 and has held it in 4 quarters since.
  • MASECO Private Wealth's AbbVie position peaked at $1.92M in Q3 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on MASECO Private Wealth's 13F filing for Q1 2026, filed 21 Apr 2026.